These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19300611)

  • 1. Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache.
    Evers S
    Neuropsychiatr Dis Treat; 2007 Dec; 3(6):761-4. PubMed ID: 19300611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating prophylactic botulinum toxin type A for chronic headache disorders.
    Evers S
    Expert Opin Investig Drugs; 2006 Oct; 15(10):1161-6. PubMed ID: 16989593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status on the use of botulinum toxin for headache disorders.
    Evers S
    Curr Opin Neurol; 2006 Jun; 19(3):310-5. PubMed ID: 16702841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxins for the prevention of migraine in adults.
    Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin and the management of chronic headaches.
    Evers S
    Curr Opin Otolaryngol Head Neck Surg; 2004 Jun; 12(3):197-203. PubMed ID: 15167029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Botulinum Toxin Type A in Headache Treatment.
    Mathew NT; Kaup AO
    Curr Treat Options Neurol; 2002 Sep; 4(5):365-373. PubMed ID: 12162925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis.
    Giri S; Tronvik E; Linde M; Pedersen SA; Hagen K
    Cephalalgia; 2023 Apr; 43(4):3331024231156922. PubMed ID: 36856015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    Jackson JL; Kuriyama A; Hayashino Y
    JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG; Diamond S; Diamond M; Urban G
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
    Blumenfeld A
    Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial.
    Pijpers JA; Kies DA; Louter MA; van Zwet EW; Ferrari MD; Terwindt GM
    Brain; 2019 May; 142(5):1203-1214. PubMed ID: 30982843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT; Frishberg BM; Gawel M; Dimitrova R; Gibson J; Turkel C;
    Headache; 2005 Apr; 45(4):293-307. PubMed ID: 15836565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.
    Sandrini G; Perrotta A; Tassorelli C; Torelli P; Brighina F; Sances G; Nappi G
    J Headache Pain; 2011 Aug; 12(4):427-33. PubMed ID: 21499747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prophylactic treatment of chronic daily headache.
    Mathew NT
    Headache; 2006; 46(10):1552-64. PubMed ID: 17115988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin type A (Relatox) in the treatment of chronic migraine in adults: results of phase IIIb, randomized, one-blind, multicenter, active-controlled, parallel-group trial].
    Artemenko AR; Abramov VG; Konovalova ZN; Korenko AN; Krasavina DA; Kurenkov AL; Latysheva NV; Naprienko MV; Orlova OR; Filatova EG; Shevchenko VS; Yakovleva PN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):89-99. PubMed ID: 37315247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
    Freitag FG
    CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin in migraine prophylaxis.
    Göbel H
    J Neurol; 2004 Feb; 251 Suppl 1():I8-11. PubMed ID: 14991336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.